TFF Pharmaceuticals Inc (TFFP) Stock Earnings & Estimates
NASDAQ:TFFP - US87241J2033 - Common Stock
0.065 USD
-0.1 (-60.05%)
0.135 USD
+0.07 (+107.69%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 90K | 500K 455.56% | 733.87K 46.77% | 1.176M 60.25% | 816K -30.61% | 11.962M 1,365.93% | |
| EBITDA YoY % growth | -31.68M -69.50% | -31.41M 0.85% | -21.392M 31.89% | 24.174M 213.00% | 23.658M -2.13% | 23.617M -0.18% | |
| EBIT YoY % growth | -31.79M -70.09% | -31.8M -0.03% | -21.895M 31.15% | -19.518M 10.86% | -25.517M -30.74% | -18.604M 27.09% | |
| Operating Margin | -35,322.22% | -6,360.00% | -2,983.45% | -1,659.67% | -3,127.13% | -155.52% | |
| EPS YoY % growth | -1.25 -38.89% | -3.46 -176.80% | -12.51 -261.56% | -4.37 65.10% | -3.85 11.92% | -2.76 28.12% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.74 62.96% | -0.44 81.73% | -0.34 72.41% | -0.29 64.74% | -0.30 60.27% |
| Revenue Q2Q % growth | 204K 78.43% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.864M 9.39% | -8.64M -49.21% | -8.81M -122.32% | -9.104M -154.14% | -9.41M -93.44% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.81 64.00% | -0.83 | 0.02 | 1.96% |
| Q2 2024 Q2Q % growth | -1.22 65.14% | -1.73 | 0.51 | 29.64% |
| Q1 2024 Q2Q % growth | -2.40 49.47% | -2.31 | -0.09 | -4.11% |
| Q4 2023 Q2Q % growth | -2.01 19.60% | -2.16 | 0.15 | 7.05% |
| Q3 2023 Q2Q % growth | -2.25 -675.86% | -2.93 | 0.68 | 23.27% |
| Q2 2023 Q2Q % growth | -3.50 -929.41% | -4.85 | 1.34 | 27.76% |
| Q1 2023 Q2Q % growth | -4.75 -1,339.39% | -5.87 | 1.12 | 19.01% |
| Q4 2022 Q2Q % growth | -2.50 -525.00% | -6.12 | 3.62 | 59.15% |
| Q3 2022 Q2Q % growth | -0.29 14.71% | -0.34 | 0.05 | 14.71% |
| Q2 2022 Q2Q % growth | -0.34 -88.89% | -0.33 | -0.01 | -4.17% |
| Q1 2022 Q2Q % growth | -0.33 | -0.39 | 0.06 | 14.86% |
| Q4 2021 Q2Q % growth | -0.40 -53.85% | -0.28 | -0.12 | -42.60% |
| Q3 2021 Q2Q % growth | -0.34 -41.67% | -0.19 | -0.15 | -75.44% |
| Q2 2021 Q2Q % growth | -0.18 10.00% | -0.31 | 0.13 | 42.46% |
| Q1 2021 Q2Q % growth | -0.33 -65.00% | -0.24 | -0.09 | -34.80% |
| Q4 2020 Q2Q % growth | -0.26 | -0.24 | -0.02 | -9.25% |
| Q3 2020 Q2Q % growth | -0.24 | -0.19 | -0.05 | -23.84% |
| Q2 2020 Q2Q % growth | -0.20 | -0.22 | 0.02 | 8.80% |
| Q1 2020 Q2Q % growth | -0.20 | -0.24 | 0.04 | 18.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 193.39K -17.71% | 204K | -10.61K | -5.20% |
| Q2 2024 Q2Q % growth | 650K 95.20% | 153K | 497K | 324.84% |
| Q1 2024 Q2Q % growth | 203K 298.04% | 76.5K | 126.5K | 165.36% |
| Q4 2023 Q2Q % growth | 114.33K -63.47% | 102K | 12.33K | 12.09% |
| Q3 2023 Q2Q % growth | 235K 161.11% | 51K | 184K | 360.78% |
| Q2 2023 Q2Q % growth | 333K 1,010.00% | 68.003K | 264.997K | 389.68% |
| Q1 2023 Q2Q % growth | 51K -27.14% | 255K | -204K | -80.00% |
| Q4 2022 Q2Q % growth | 313K 3,030.00% | 20.4K | 292.6K | 1,434.31% |
| Q3 2022 Q2Q % growth | 90K 80.00% | 90K | % | |
| Q1 2022 Q2Q % growth | 70K 250.00% | 51K | 19K | 37.25% |
| Q4 2021 Q2Q % growth | 10K | 957.27K | -947.27K | -98.96% |
| Q3 2021 Q2Q % growth | 50K | 1.734M | -1.684M | -97.12% |
| Q4 2020 Q2Q % growth | 255K | -255K | -100.00% | |
| Q3 2020 Q2Q % growth | 510K | -510K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 22.34% | 0% | 0% |
| Revenue | 0% | 166.67% | 0% | 0% |